Company Profiles

driven by the PitchBook Platform

Creabilis

Creabilis
2003 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$150M LATEST DEAL AMOUNT
Description

Developer of pharmaceuticals for treatment of dermatological and inflammatory diseases. The company's lead product, CT327, is a topical treatment for chronic pruritus. It intents to build a pruritus franchise around the CT327 and CT340 candidates which were developed using the company's proprietary Low Systemic Exposure (LSE) platform technology.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6 Denne Hill Business Centre
  • Womenswold
  • Canterbury CT4 6HD
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Creabilis’s full profile, request a free trial.

Creabilis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Dec-2016 $150M 000.00 00000 Completed Clinical Trials - Phase 2
3. Grant 05-Nov-2012 00.000 000.00 Completed Startup
2. Later Stage VC (Series B) 04-Oct-2011 $20M $51.1M Completed Startup
1. Early Stage VC (Series A) 05-Jun-2008 $31.1M $31.1M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Creabilis Investments & Acquisitions (2)

Company Name Date Type Deal Size Industry Lead Partner
00000000 0000000 30-Apr-2007 00000 00000 00 000.00 Biotechnology
Nautilus Biotech 01-Mar-2005 Later Stage VC 00.00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Creabilis Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Kreos Capital Growth/Expansion Minority 000 0000 000000 0
NeoMed Management Venture Capital Minority 000 0000 000000 0
Sofinnova Partners Venture Capital Minority 000 0000 000000 0

Creabilis Executive Team (10)

Name Title Board
Seat
Contact
Info
Alex Leech Chief Executive Officer & Board Member
Silvio Traversa Ph.D Chief Scientific Officer
Alfredo Boni Founder & Board Member
Simon Russell Ph.D Chief Business Officer
David Roblin Chief Medical Officer

4 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Creabilis Board Members (8)

Name Representing Role Since Contact
Info
Alex Leech Creabilis Chief Executive Officer & Board Member 000 0000
Alfredo Boni Creabilis Founder & Board Member 000 0000

6 Former Board Members

You’re viewing 2 of 8 board members. Get the full list »